AAAAAA

   
Results: 1-20 |
Results: 20
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment
Authors: Sarmati, L d'Ettorre, G Nicastri, E Ercoli, L Uccella, I Massetti, P Parisi, SG Vullo, V Andreoni, M
Citation: L. Sarmati et al., Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment, CL DIAG LAB, 8(4), 2001, pp. 822-824
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression
Authors: Grelli, S Di Traglia, L Matteucci, C Lichtner, M Vullo, V Di Sora, F Lauria, F Montella, F Favalli, C Vella, S Macchi, B Mastino, A
Citation: S. Grelli et al., Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression, AIDS, 15(9), 2001, pp. 1178-1181
Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia
Authors: Mastroianni, CM d'Ettorre, G Forcina, G Lichtner, M Corpolongo, A Coletta, S Vullo, V
Citation: Cm. Mastroianni et al., Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia, AIDS, 15(6), 2001, pp. 820-821
Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens
Authors: Dorrucci, M Pezzotti, P Grisorio, B Minardi, C Muro, MS Vullo, V Monforte, AD
Citation: M. Dorrucci et al., Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens, AIDS, 15(13), 2001, pp. 1733-1736
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations
Authors: Sarmati, L Nicastri, E Parisi, SG D'Ettorre, G Narciso, P Mancino, G Gallo, I Abbadessa, V Dalle, NER Traina, C Vullo, V Andreoni, M
Citation: L. Sarmati et al., Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations, J MED VIROL, 65(4), 2001, pp. 631-636
Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus
Authors: Nicastri, E Ercoli, L Sarmati, L d'Ettorre, G Iudicone, P Massetti, P Vullo, V Andreoni, M
Citation: E. Nicastri et al., Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus, J MED VIROL, 64(3), 2001, pp. 232-237
Changes in circulating levels of soluble cell adhesion molecules followinghighly active antiretroviral treatment of HIV-1-infected patients
Authors: Mastroianni, CM Lichtner, M Mengoni, F D'Agostino, C d'Ettorre, G Forcina, G Santopadre, P Massetti, AP Vullo, V
Citation: Cm. Mastroianni et al., Changes in circulating levels of soluble cell adhesion molecules followinghighly active antiretroviral treatment of HIV-1-infected patients, CLIN IMMUNO, 95(3), 2000, pp. 212-217
HSV-2 specific seroprevalence among various populations in Rome, Italy
Authors: Suligoi, B Cusan, M Santopadre, P Palu, G Catania, S Girelli, G Pala, S Vullo, V
Citation: B. Suligoi et al., HSV-2 specific seroprevalence among various populations in Rome, Italy, SEX TRANS I, 76(3), 2000, pp. 213-214
Increased activity of matrix metalloproteinases in the cerebrospinal fluidof patients with HIV-associated neurological diseases
Authors: Liuzzi, GM Mastroianni, CM Santacroce, MP Fanelli, M D'Agostino, C Vullo, V Riccio, P
Citation: Gm. Liuzzi et al., Increased activity of matrix metalloproteinases in the cerebrospinal fluidof patients with HIV-associated neurological diseases, J NEUROVIRO, 6(2), 2000, pp. 156-163
Sexual behaviour of women living with HIV/AIDS naive for antiretroviral therapy: the ICONA-BEHEPI Study
Authors: Aloisi, MS Serraino, D Girardi, E Lauria, FN Monforte, AD Cargnel, A Bonazzi, I Petrosillo, N Abrescia, N Mazzotta, F Vullo, V Ferraro, T Suter, F Masi, A Rezza, G Ippolito, G
Citation: Ms. Aloisi et al., Sexual behaviour of women living with HIV/AIDS naive for antiretroviral therapy: the ICONA-BEHEPI Study, AIDS CARE, 12(6), 2000, pp. 789-795
Overexpression of lymphocytic GD3 ganglioside and presence of anti-GD3 antibodies in patients with HIV infection
Authors: Misasi, R Sorice, M Garofalo, T Griggi, T Giammarioli, AM D'Ettorre, G Vullo, V Pontieri, GM Malorni, W Pavan, A
Citation: R. Misasi et al., Overexpression of lymphocytic GD3 ganglioside and presence of anti-GD3 antibodies in patients with HIV infection, AIDS RES H, 16(15), 2000, pp. 1539-1549
Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy
Authors: Grelli, S Campagna, S Lichtner, M Ricci, G Vella, S Vullo, V Montella, F Di Fabio, S Favalli, C Mastino, A Macchi, B
Citation: S. Grelli et al., Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy, AIDS, 14(8), 2000, pp. 939-949
Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: Report of two cases
Authors: Mastroianni, CM d'Ettorre, G Forcina, G Corpolongo, A Dell'Isola, S Lichtner, M D'Agostino, C Trinchieri, V Santopadre, P Vullo, V
Citation: Cm. Mastroianni et al., Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: Report of two cases, J INFECTION, 40(1), 2000, pp. 94-96
A spot weld finite element for structural modelling
Authors: Salvini, P Vivio, F Vullo, V
Citation: P. Salvini et al., A spot weld finite element for structural modelling, INT J FATIG, 22(8), 2000, pp. 645-656
Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis
Authors: Mastroianni, CM Mengoni, F Lichtner, M D'Agostino, C d'Ettorre, G Forcina, G Marzi, M Russo, G Massetti, AP Vullo, V
Citation: Cm. Mastroianni et al., Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis, J INFEC DIS, 182(5), 2000, pp. 1536-1539
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection
Authors: Mastroianni, CM d'Ettorre, G Forcina, G Lichtner, M Mengoni, F D'Agostino, C Corpolongo, A Massetti, AP Vullo, V
Citation: Cm. Mastroianni et al., Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection, BLOOD, 96(5), 2000, pp. 1979-1984
Search for an antibody profile of Rhodococcus equi infection in AIDS patients despite the diversity of isolates and patient immune dysfunction
Authors: Caterino-de-Araujo, A de los Santos-Foruna, E Zandona-Meleiro, MC Mastroianni, CM Lichtner, M Mengoni, F Vullo, V
Citation: A. Caterino-de-araujo et al., Search for an antibody profile of Rhodococcus equi infection in AIDS patients despite the diversity of isolates and patient immune dysfunction, MICROBES IN, 1(9), 1999, pp. 663-670
Reversal of AIDS dementia after combination therapy with stavudine, lamivudine, and nelfinavir
Authors: Mastroianni, CM Trinchieri, V Santopadre, P Lichtner, M Forcina, G D'Agostino, C Dell'Isola, S Vullo, V
Citation: Cm. Mastroianni et al., Reversal of AIDS dementia after combination therapy with stavudine, lamivudine, and nelfinavir, J NEUROL, 246(10), 1999, pp. 972-973
Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients
Authors: Mastroianni, CM Lichtner, M Mengoni, F D'Agostino, C Forcina, G d'Ettorre, G Santopadre, P Vullo, V
Citation: Cm. Mastroianni et al., Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients, AIDS, 13(8), 1999, pp. 883-890
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects
Authors: Nicastri, E Sarmati, L Ercoli, L Mancino, G D'Ambrosio, E d'Ettorre, G Mastroianni, CM Vullo, V Andreoni, M
Citation: E. Nicastri et al., Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects, AIDS, 13(11), 1999, pp. 1333-1336
Risultati: 1-20 |